Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Lingxi Wei,
No information about this author
Wenqi Yan,
No information about this author
Wahid Shah
No information about this author
et al.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(16), P. e35836 - e35836
Published: Aug. 1, 2024
Stem
cell
transplantation
has
emerged
as
a
promising
avenue
in
regenerative
medicine,
potentially
facilitating
tissue
repair
degenerative
diseases
and
injuries.
This
review
comprehensively
examines
recent
developments
challenges
stem
transplantation.
It
explores
the
identification
isolation
of
various
types,
including
embryonic,
induced
pluripotent,
adult
cells
derived
from
multiple
sources.
Additionally,
highlights
tissue-specific
applications
these
cells,
focusing
on
bone
cartilage
regeneration,
treatment
neurological
disorders,
management
hematological
conditions.
Future
advancements
effective
resolution
current
will
be
crucial
fully
realizing
potential
medicine.
With
responsible
ethical
practices,
field
can
transform
disease
injury
treatment,
ultimately
improving
quality
life
for
countless
individuals.
Language: Английский
TCP80-1, a new levan-neoseries fructan from Tupistra chinensis Baker rhizomes alleviates ulcerative colitis induced by dextran sulfate sodium in Drosophila melanogaster model
Tanggan Wang,
No information about this author
Zhong‐Nan Wu,
No information about this author
Meifeng Li
No information about this author
et al.
Food Research International,
Journal Year:
2025,
Volume and Issue:
203, P. 115860 - 115860
Published: Jan. 31, 2025
Language: Английский
MOLECULAR MECHANISM AND THERAPEUTIC POTENTIAL OF BERBERINE, BAICALEIN, ORIDONIN IN THE TREATMENT OF COLORECTAL CANCER – A REVIEW
Sonia Ramamoorthy,
No information about this author
Jegadeesh Ramasamy,
No information about this author
GOPINATH SAMBASIVAM
No information about this author
et al.
Asian Journal of Pharmaceutical and Clinical Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 31 - 43
Published: April 7, 2025
The
aim
of
this
research
is
to
assess
the
effect
berberine
and
baicalein
oridonin
(ORI)
treatment
on
colorectal
cancer
(CRC)
cells.
examines
how
these
compounds
bring
about
cellular
alterations,
stop
cell
cycle
progression,
trigger
death.
cancer-fighting
agents
together
with
ORI
demonstrate
strong
anticancer
properties
against
CRC
tissues
through
metabolic
instability
arrest
leading
apoptosis.
affects
activation
TP53/TCF4
mechanisms
which
creates
endoplasmic
reticulum
stress
then
leads
higher
reactive
oxygen
species
production
alongside
calcium
ion
imbalances.
retinoid
X
receptor
alpha
mechanism
performs
better
than
in
colon
growth
inhibition.
Berberine
suppresses
progression
its
ability
influence
transforming
factor-beta
signaling
pathway
inhibitory
action
epithelial-mesenchymal
transition
weakening
liver
metastasis.
altered
composition
gut
microbes
reduces
tissue
tumorigenesis
as
well
total
microbial
abundance.
shows
anti-metastatic
capabilities
by
blocking
actions
matrix
metallopeptidase
(MMP)-2
MMP-9
enzymes
play
important
roles
cells
spreading
during
suppression
occurs
berberine-mediated
G2/M
death
that
results
cyclin
B1
cdc2
cdc25c
protein
downregulation.
anti-inflammatory
agent
acts
a
major
element
developing
tumorous
lesions
associated
colitis.
compound
speeds
up
phase
role
regulating
toll-like
4/nuclear
factor-kappa
B
HT-29
regulatory
process
decrease
stems
from
inflammation
while
also
restricting
multiplication.
Language: Английский
M64HCl, a focal adhesion kinase activator, promotes intestinal mucosal healing in rats
BMC Gastroenterology,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: May 8, 2025
Intestinal
mucosal
injury
may
arise
from
various
factors.
While
many
drugs
target
the
causative
factors,
none
directly
stimulate
wound
healing.
We
found
that
specific
focal
adhesion
kinase
(FAK)
activator,
M64HCl,
promotes
intestinal
healing
in
mice.
This
study
aims
to
further
validate
therapeutic
impact
of
M64HCl
on
repair
rats
as
a
second
species.
Wistar
were
assigned
one
four
groups:
normal
control,
1-day
+
vehicle,
4-day
or
M64HCl.
was
induced
by
serosally
applying
75%
acetic
acid.
Immediately
after
injury,
received
either
continuous
infusion
(25
mg/kg/day)
its
vehicle
(saline).
Four
days
post-injury,
blood
drawn
measure
levels
and
assess
liver
kidney
function.
The
intestines
removed
opened,
ulcer
areas
photographed
for
size
quantification,
tissues
fixed
histological
immunohistochemical
analysis.
substantially
reduced
area
gross
examination,
while
analysis
showed
alleviation
pathological
changes
with
treatment.
Immunohistochemical
confirmed
increased
immunoreactivity
phosphorylated
FAK
epithelium
adjacent
M64HCl-treated
rats.
However,
there
no
change
percentage
Ki67-positive
cells
each
crypt
at
edge
area.
Serum
creatinine,
ALT,
AST
did
not
differ
between
groups
without
water-soluble
acid-induced
be
useful
treating
gastrointestinal
injury.
Language: Английский
Nisin A elevates adenosine to achieve anti-inflammatory activity
Food & Function,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
This
study
uncovers
that
nisin
A
achieves
excellent
anti-inflammatory
activity
via
enhancing
the
level
of
adenosine,
followed
by
up-regulation
sphingolipid
signaling
pathway
and
down-regulation
purine
metabolism.
Language: Английский
Understanding how the immune system environment is controlled in high myopia cases
Xin Qiao,
No information about this author
Wahid Shah,
No information about this author
Xiaoqin Gao
No information about this author
et al.
International Immunopharmacology,
Journal Year:
2024,
Volume and Issue:
143, P. 113138 - 113138
Published: Oct. 2, 2024
Language: Английский
The molecular determinants of phenotypic plasticity in homeostasis and neoplasia
Bradley Balk,
No information about this author
David W. Goodrich
No information about this author
Published: Dec. 13, 2024
Phenotypic
plasticity,
the
capacity
of
cells
to
transition
between
distinct
phenotypic
and
lineage
states
over
time,
is
a
genetically
epigenetically
encoded
trait
essential
for
normal
development
adult
tissue
homeostasis.
In
cancer,
plasticity
programs
can
be
deployed
aberrantly
enable
disease
progression
acquired
therapeutic
resistance.
Cancer
current
barrier
achieving
cures
advanced
cancers
using
available
molecularly
targeted
therapies.
This
review
summarizes
complex
interconnected
molecular
pathways
implicated
in
both
context
homeostasis
cancer.
Molecular
convergent
these
contexts
are
highlighted
while
enabling
distinguished
from
those
that
specify
phenotype
already
plastic
cells.
Key
unresolved
questions
field
discussed
along
with
emerging
technologies
may
used
help
answer
them.
Language: Английский